All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF276 | Anti-Human CLDN18.2 (XW-276) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-276 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF277 | Anti-Mouse CLDN18.2 (XW-277) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-277 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF278 | Anti-Human CLDN18.2 (XW-278) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-278 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF279 | Anti-Human CLDN18.2 (XW-279) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-279 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF280 | Anti-Human CLDN18.2 (XW-280) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-280 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF281 | Anti-Mouse CLDN18.2 (XW-281) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-281 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF282 | Anti-Human CLDN18.2 (XW-282) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-282 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF283 | Anti-Human CLDN18.2 (XW-283) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-283 | Humanized | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF284 | Anti-Human CLDN18.2 (XW-284) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-284 | Humanized | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF285 | Anti-Human CLDN18.2 (XW-285) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-285 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1196 | Anti-Human CLDN18.2 (XW-276) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-276 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1197 | Anti-Mouse CLDN18.2 (XW-277) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-277 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1198 | Anti-Human CLDN18.2 (XW-278) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-278 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1199 | Anti-Human CLDN18.2 (XW-279) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-279 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1200 | Anti-Human CLDN18.2 (XW-280) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-280 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1201 | Anti-Mouse CLDN18.2 (XW-281) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-281 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1202 | Anti-Human CLDN18.2 (XW-282) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-282 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1203 | Anti-Human CLDN18.2 (XW-283) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-283 | Humanized | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1204 | Anti-Human CLDN18.2 (XW-284) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-284 | Humanized | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1205 | Anti-Human CLDN18.2 (XW-285) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-285 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0823-LX29 | Anti-hCLDN18.2 (182511) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 182511 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION